HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.

Abstract
Central nervous system tumors carry grave clinical prognoses due to limited effectiveness of surgical resection, radiation, and chemotherapy. Thus, improved strategies for brain tumor visualization and targeted treatment are critically needed. We demonstrate that mouse cerebellar medulloblastoma (MB) can be targeted and illuminated with a fluorescent, engineered cystine knot (knottin) peptide that binds with high affinity to αvβ3, αvβ5, and α5β1 integrin receptors. This integrin-binding knottin peptide, denoted EETI 2.5F, was evaluated as a molecular imaging probe in both orthotopic and genetic models of MB. Following tail vein injection, fluorescence arising from dye-conjugated EETI 2.5F was localized to the tumor compared with the normal surrounding brain tissue, as measured by optical imaging. The imaging signal intensity correlated with tumor volume. Due to its unique ability to bind to α5β1 integrin, EETI 2.5F showed superior in vivo and ex vivo brain tumor imaging contrast compared with other engineered integrin-binding knottin peptides and with c(RGDfK), a well-studied integrin-binding peptidomimetic. Next, EETI 2.5F was fused to an antibody fragment crystallizable (Fc) domain (EETI 2.5F-Fc) to determine if a larger integrin-binding protein could also target intracranial brain tumors. EETI 2.5F-Fc, conjugated to a fluorescent dye, illuminated MB following i.v. injection and was able to distribute throughout the tumor parenchyma. In contrast, brain tumor imaging signals were not detected in mice injected with EETI 2.5F proteins containing a scrambled integrin-binding sequence, demonstrating the importance of target specificity. These results highlight the potential of using EETI 2.5F and EETI 2.5-Fc as targeted molecular probes for brain tumor imaging.
AuthorsSarah J Moore, Melanie G Hayden Gephart, Jamie M Bergen, YouRong S Su, Helen Rayburn, Matthew P Scott, Jennifer R Cochran
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 110 Issue 36 Pg. 14598-603 (Sep 03 2013) ISSN: 1091-6490 [Electronic] United States
PMID23950221 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Cystine-Knot Miniproteins
  • Fluorescent Dyes
  • Integrin alpha5beta1
  • Patched Receptors
  • Receptors, Cell Surface
  • Green Fluorescent Proteins
Topics
  • Animals
  • Cerebellar Neoplasms (diagnosis, genetics, metabolism)
  • Cystine-Knot Miniproteins (chemistry, genetics, metabolism)
  • Diagnostic Imaging (methods)
  • Female
  • Fluorescent Dyes (chemistry, metabolism)
  • Green Fluorescent Proteins (genetics, metabolism)
  • Integrin alpha5beta1 (metabolism)
  • Male
  • Medulloblastoma (diagnosis, genetics, metabolism)
  • Mice
  • Mice, Knockout
  • Mice, Nude
  • Mice, Transgenic
  • Microscopy, Fluorescence
  • Molecular Imaging (methods)
  • Patched Receptors
  • Protein Binding
  • Protein Engineering
  • Receptors, Cell Surface (genetics, metabolism)
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: